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Copy number variation can contribute to the variation observed in susceptibility to complex diseases.
Here we present the ﬁrst study to investigate copy number variation of the chemokine gene CCL3L1 with
susceptibility to malaria. We present a family-based genetic analysis of a Tanzanian population (n = 922),
using parasite load, mean number of clinical infections of malaria and haemoglobin levels as phenotypes.
Copy number of CCL3L1was measured using the paralogue ratio test (PRT) and the dataset exhibited copy
numbers ranging between 1 and 10 copies per diploid genome (pdg). Association between copy number
and phenotypes was assessed. Furthermore, we were able to identify copy number haplotypes in some
families, using microsatellites within the copy variable region, for transmission disequilibrium testing.
We identiﬁed a high level of copy number haplotype diversity and ﬁnd some evidence for an association
of low CCL3L1 copy number with protection from anaemia.
 2012 Elsevier B.V. All rights reserved.1. Introduction
Malaria caused by Plasmodium falciparum is a major cause of
mortality and morbidity, especially in sub-Saharan Africa. Individ-
uals who live in endemic areas may be subjected to constant expo-
sure to infective mosquito bites and depending on the level of
immunity, develop parasitaemia (parasites in the blood) and/or
clinical disease. Variations in disease pattern can be attributable
to a number of factors, including host genetic background, which
was recently shown to account for approximately a quarter of
the total variation observed in susceptibility to malarial diseases
(Mackinnon et al., 2005).
Resolution of P. falciparum infection requires the production of
cytokines, and the activation of macrophages leading to the
destruction of parasites (Luty et al., 2001). Activation of macro-
phages and the recruitment to sites of infection is through chemo-
attractant cytokines, including macrophage inﬂammatory protein
(MIP-1a, a small, low molecular weight, b-chemokine. This chemo-
kine is secreted from most mature leucocytes and acts as a pro-
inﬂammatory cytokine, being inhibited by IL-4, IL-10 and IL-13
(Berkman et al., 1995; Standiford et al., 1993).
The genes CCL3 and CCL3L1 encode the MIP-1a isoforms LD78a
and LD78b respectively. The mature MIP-1a isoforms differ at only
3 amino acids, at positions 3, 39 and 47, with the isoform LD78b
being 2-fold more efﬁcient at chemoattracting human monocytesll rights reserved.
x: +44 115 8230338.
.uk (D. Carpenter).and lymphocytes than the LD78a isoform (Menten et al., 1999).
The gene CCL3L1 is copy variable and is located on chromosome
17q12 in a repeat unit of approximately 90 kb. Each repeat unit
contains a single copy of CCL3L1 and a single copy of another copy
variable chemokine gene, CCL4L1, and is ﬂanked by the gene
TBC1D3. The repeat unit neighbours the paralogous, but copy
invariant, genes CCL3 and CCL4 (Irving et al., 1990), and is thought
to have evolved by duplication of the CCL3 and CCL4 region and
subsequent divergence. Consequently CCL3 and CCL3L1 and also
CCL4 and CCL4L1 exhibit a high degree (96%) of both nucleotide
and protein sequence identity.
The CCL3L1/CCL4L1 copy-variable region is of further interest as
it varies markedly between populations; European populations ex-
hibit a range of between 0 and 5 copies per diploid genome (pdg),
with a modal copy of 2 (Carpenter et al., 2011; Gonzalez et al.,
2005; Townson et al., 2002), whereas African populations have a
greater range of between 2 and 10 pdg, with a modial copy of 4
(Gonzalez et al., 2005). It is not known why there is such diver-
gence in copy number between populations but it has been sug-
gested that there could be some recent population-speciﬁc
selective force acting (Redon et al., 2006).
MIP-1a has previously been shown to play a role in protozoan
infections; an increase in MIP-1a expression is observed in
response to Toxoplasma gondii (Bliss et al., 1999) and Leishmania
(Ritter et al., 1996; Teixeira et al., 2005). Serum concentrations of
MIP-1a were shown to increase to a maximum 14 days post diag-
nosis in Thai malaria patients, suggesting that whilst MIP-1a is not
involved in the acute phase of malaria infection, it may play a role
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et al., 1995). Furthermore MIP-1a protein and mRNA expression
have been shown to be signiﬁcantly elevated in the plasma of chil-
dren with both mild and severe malaria (Ochiel et al., 2005), induc-
ing proliferation of macrophages and expression of TNF-a, and
exposure to P. falciparum antigens enhances MIP-1a production
in neonates (Kocherscheidt et al., 2010). There is also evidence that
MIP-1a inhibits haematopoietic stem cell proliferation (Graham
and Pragnell, 1992; Graham et al., 1990), which may contribute
to the malarial anaemia phenotype.
The involvement of MIP-1a in the pathology of P. falciparum
infection makes malaria an attractive candidate to have exerted
signiﬁcant selective pressure on CCL3L1 copy number in the past.
Here we investigate whether copy number variation of CCL3L1
may play a role in susceptibility to parasite prevalence and high
loads, mean number of clinical episodes of malaria and haemoglo-
bin levels in a longitudinal study of a rural Tanzanian population
living in the Ruﬁji river delta. Furthermore, as the data set allows
family based analysis this will allow us to use segregation to dis-
sect the different haplotype backgrounds to allow transmission
disequilibrium testing (TDT) analysis.
This method of genotyping CCL3L1 copy number has previously
only been used on European samples where it has been shown to
be an accurate and reproducible method to genotype copy number
(Carpenter et al., 2011; Walker et al., 2009). However, African sam-
ples exhibit higher copy number values (Gonzalez et al., 2005) and
potentially a more complex pattern of variation at this locus
(Walker et al., 2009). As such the PRT method was further devel-
oped for use with African samples.2. Materials and methods
2.1. Study population
The study population is the well described Tanzanian Bantu
population from the ﬁshing village of Nyamisati, in the Ruﬁji river
delta, 150 km south of Dar-es-Salaam (Carpenter et al., 2007, 2009;
Rooth, 1992). The region was holoendemic for malaria with trans-
mission increasing during the two rainy seasons (April–June and
November–December). The predominant malaria species is P. falci-
parum and parasite prevalence in 1993 was 75% falling to 48% in
1998 as measured by microscopy in the 2–9 year old children.
Cerebral malaria was not observed in the village during 1985–
1999 when a research team provided health care in the village.
Human genomic DNA was extracted from frozen packed cells
sampled in EDTA from a total of 1050 samples, as previously de-
scribed (Carpenter et al., 2007, 2009) with informed consent and
approval of the local ethics committees by the National Institute
of Medical Research of Tanzania and the Regional Ethical Commit-
tee of Stockholm, Sweden. There were 15 individuals in the village
known to be positive for HIV-1; for health and safety reasons DNA
was not extracted from these samples, and these samples are ex-
cluded from any genetic analysis.2.2. Phenotypes
The three clinical phenotypes (parasite load, mean number of
clinical episodes of malaria and haemoglobin levels) were gener-
ated from data collected in Nyamisati from 1993 to 1999, using an-
nual non-selected ‘total’ population surveys carried out during
March and April, and a complete annual record of clinical malaria
episodes all documented and collected by I.R., living in the village
since 1985 (Rooth, 1992). The parasite load and mean number of
clinical episodes of malaria data have previously been described
in detail (Carpenter et al., 2009); in brief, the annual populationsurveys provided longitudinal data on ‘asymptomatic’ parasite
densities (parasites per ll blood) recorded between March and
April. The annual records gave the total number of clinical episodes
each year per year per person, deﬁned as fever (>37.5 C) together
with >5000 P. falciparum parasites/ll blood on microscopy. To gen-
erate a quantitative trait the data for both these phenotypes was
log-transformed and corrected for age and sex for each year that
data was collected (1993–1999). An arithmetic mean of the resid-
uals generated from this correction for each year (1993–1999) was
calculated to produce a single quantitative value for asymptomatic
parasite load (p/ll) and for mean number of clinical episodes of
malaria for use in the genetic analysis (Carpenter et al., 2009).
The population surveys contain information on haemoglobin
concentration (g/l) for years 1994 to 1999. The majority of the
1289 individuals recorded in the population surveys do not have
data from all years, but individuals have an average of 1.75 entries
(range 1–4). To generate a single quantitative trait from the longi-
tudinal haemoglobin data the mean haemoglobin was calculated
per sample. Age and sex correction was carried out annually using
a general linear model with age, age2 and sex as covariates. A small
proportion (1%) of these individuals also presented with clinical
episodes at the time of survey, when cross referenced with the
clinical episode records for March to May, and for these samples
only the peak parasite load (parasite/ll) was also included as a
covariate in the general linear model to take into account the effect
of parasite load on haemoglobin values. The residuals were re-
corded for each year (1994–1999) and the arithmetic mean was
subsequently calculated to give a single quantitative value for hae-
moglobin level (see Fig. 3) (Carpenter, 2003).
2.3. Copy number measurement
Copy number was measured from genomic DNA using the par-
alogue ratio test (PRT) previously described (Carpenter et al., 2011;
Walker et al., 2009). Brieﬂy, the PRT method is a PCR-based assay
using a single pair of primers to simultaneously amplify two spe-
ciﬁc products in a single reaction, one from a single-copy reference
locus and the other from the copy variable test locus of interest.
The copy number of the test locus is then estimated from the ratio
of test to reference PCR products. In European samples a single-
tube triplex PRT assay has previously been described (Carpenter
et al., 2011), using three independent PRT assays (CCL3C, CCL4A
and LTR61A) to give three measures of copy number, which are
then averaged into a single unrounded copy number value. In the
African samples here the single tube triplex assay was performed
in triplicate with different dyes; a FAM-labelled single tube triplex,
a HEX-labelled triplex and a NED-labelled triplex, ultimately giving
nine separate ratios of test to reference products. Two microsatel-
lite PCRs were also performed for each sample as described previ-
ously (Walker et al., 2009). For each sample the products from the
three triplex PCR reactions and the two microsatellites were mixed
with 10 ll HiDi formamide with ROX-500 marker (Applied Biosys-
tems, UK) for analysis. Fragment analysis was carried out by elec-
trophoresis on an ABI3100 36 cm capillary using POP-4 polymer
with an injection time of 30s at 2 kV (see Supplementary Fig. 1).
GeneMapper software (Applied Biosystems, UK) was used to ex-
tract the peak heights for the three systems and the ratio of test
peak height to reference peak height was calculated for each sam-
ple for each dye independently. Copy number values were calcu-
lated by calibrating the ratios from each experiment with 5
Yoruba HapMap samples (http://www.coriell.org/) of established
copy number [copy number (CN) = 2, NA19159; CN = 3,
NA18870; CN = 4, NA19092; CN = 5, NA19171; and CN = 6,
NA18503], which were included in every experiment in triplicate.
Unrounded and calibrated copy numbers were compared and an
average copy number value calculated. The average copy number
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ger copy number (see further discussion in the supplementary re-
sults). In order to allow family based analysis, copy number
haplotypes were determined in some families using segregation
of microsatellite alleles.2.4. Statistical analysis
Heritabilities of the parasite density, clinical episode and hae-
moglobin phenotypes were calculated by variance components
analysis as implemented in SOLAR (Blangero and Almasy, 1997).
The number of relative pairs contributing to each heritability anal-
ysis was calculated using the ‘relpairs’ command in SOLAR. The
numbers of relative pairs were 1937 for parasite load, 2101 for
clinical episodes and 1887 for haemoglobin. For the parasite load
this included 669 parent–offspring comparisons, 847 sibling, or
half sibling, 115 grandparent–grandchild, 62 avuncular or half
avuncular and 16 ﬁrst–cousin comparisons. For the clinical epi-
sodes this included 715 parent–offspring comparisons, 927 sibling
or half sibling, 4 grandparent–grandchild, 73 avuncular or half
avuncular and 16 ﬁrst–cousin comparisons. For the haemoglobin
this included 659 parent–offspring comparisons, 823 sibling or half
sibling, 2 grandparent–grandchild, 48 avuncular or half avuncular
and 16 ﬁrst–cousin comparisons.
In order to evaluate the effect of total copy number on the ma-
laria phenotypes within the family study the variance components
analysis within SOLAR was used. This allows copy number to be
modelled as a covariate in order to evaluate the proportion of var-
iance attributable to it. Copy number was modelled as a covariate
with copy number2, age, sex and age2 included, with all the inter-
actions. Those terms that were non-signiﬁcant were removed
successively.
To allow family based analysis, parental information was col-
lected and a total of 167 extended pedigrees compiled, as previ-
ously described (Carpenter et al., 2007, 2009). Associations
between the clinical phenotypes and copy number haplotypes
were tested by a quantitative transmission disequilibrium test
(TDT) using the program QTDT version 2.1.3 (Abecasis et al.,
2000). To control for any population stratiﬁcation, we tested the
within-family association in an orthogonal model including age
and sex as covariates and environmental, polygenic heritability
and additive major locus variance components. Total evidence of
association was also modelled including age and sex as covariates
and environmental, polygenic heritability and additive major locus
variance components.3. Results
3.1. Copy number measurements
In total there were 922 Tanzanian samples successfully geno-
typed for CCL3L1 copy number. The distribution of unrounded copy
numbers is shown in Fig. 1 (and as integers in Table 1) and suggests
a range of 1–10 copies, with a mean copy number of about 4. In
general the concordance between the nine PRT measurements is
strong, with 76% of samples having all measurements concordant
within 0.75 of the inferred integer, and the microsatellite data in
agreement with the proposed integer from PRT in 89% of samples
(see Fig. 1 and discussed in Supplementary results).
The overall standard deviation (normalised for copy number) of
the full dataset was 0.07, which is small and consistent with previ-
ously typed European datasets (Carpenter et al., 2011; Walker
et al., 2009), indicating the precision of the PRT measurements in
estimating integer copy number. The mean and standard deviation,
normalised standard deviations and predicted probability of errorfor the full dataset are shown in Supplementary Table 1. The data
show that, at least for copy numbers less than 8, the means lie
within 0.1 of the corresponding integer and that the standard devi-
ations are sufﬁciently low that the probability of assigning a sam-
ple to the wrong integer class is also small. Whilst the estimates of
the probability of error of copy number calling are small, there is
an increase for higher copy numbers which is likely the result of
the greater variance observed at the higher copies.
The microsatellite alleles were used to allow determination of
the copy number haplotypes by segregation. Unambiguous segre-
gation was observed in 75/165 families (45%), which comprise a to-
tal of 591 informative individuals, comprised of 288 males, 303
females, an age range of between 1 and 86, and with a mean pedi-
gree size of 14 individuals. Fig. 2 shows that the inference of hap-
lotypes does not select a subset of individuals with distorted copy
number distribution. In total there were 194 independent individ-
uals that were phased for copy number, resulting in 388 phased
copy number haplotypes. A breakdown of the more frequent copy
number haplotypes, with the composite microsatellite alleles, is
shown in Supplementary Table 2. The overall distribution of the
haplotypes is shown in Table 2, demonstrating a range of 0–6 cop-
ies per chromosome and a mean of about 2.1 copies per chromo-
some. The data show that of the 388 haplotypes 179 are one of
the 48 more frequent, leaving 209 (54%) haplotypes that are repre-
sented only once (see Supplementary Table 2). This suggests a high
level of microsatellite allele diversity with a large number of differ-
ent copy number haplotypes represented here.
3.2. Genetic analysis of association
The phenotypes used in this study were generated from longi-
tudinal data collected in Nyamisati during 1993–1999. The epide-
miology of the parasite load and the mean number of clinical
episodes of malaria phenotypes have been discussed in detail pre-
viously (Carpenter et al., 2009), and for haemoglobin is shown in
Table 3. The distribution of haemoglobin was signiﬁcantly different
(p < 0.001) between the sexes with a mean male haemoglobin con-
centration of 114.86 g/l ± 22.32, and a female concentration of
108.42 g/l ± 16.84. A signiﬁcant positive relationship with age
was also observed (p < 0.001), and therefore the haemoglobin data
required age and sex correction, as well as correction for parasite
load, prior to further genetic analysis.
As assessed by SOLAR the heritability (SE) of the haemoglobin
data (g/l) was 0.302 (0.085) (p < 0.0001). The heritabilities of the
parasite load phenotype (0.104 (SE = 0.052)) and of the mean num-
ber of clinical episodes of malaria phenotype (0.221(SE = 0.046))
have been measured previously (Carpenter et al., 2009). There is
strong evidence from the QTDT analysis here that there is a poly-
genic component for all three malaria phenotypes: parasite load
(p = 0.0066), mean number of clinical episodes of malaria
(p = 2.5  1003) and haemoglobin (p = 9.1  1004).
The output of the variance components analysis within SOLAR
for all three phenotypes are summarised and presented in Table
4. The variance components analysis found no evidence for a sig-
niﬁcant association of total copy number with any of the malaria
phenotypes. However there was some evidence for an association
of copy number squared and haemoglobin (p = 0.035), which sug-
gests that any effect of total copy number on haemoglobin levels
is non-linear, and also a weak correlation with age  sex
(p = 0.049) was observed. Weak evidence for an effect of copy num-
ber squared was also observed with mean number of clinical epi-
sodes of malaria (p = 0.041), again suggesting that any effect of
total copy number on mean number of clinical malaria episodes
is non-linear. There was also evidence with the number of clinical
malaria episodes phenotype for a strong effect of age (p = 0.001)
and the interaction sex  total copy number (p = 0.034).
Fig. 1. Distribution of average calibrated copy number values for the 922 typed malaria samples (a), and with microsatellite data also included (b) and represented by a
different colour for each integer microsatellite.
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were generated through segregation using the microsatellite al-
leles that are situated within the copy variable region, but this is
not possible for all families, and therefore the analysis is on arestricted sample. A summary of the output of these analyses are
presented in Table 5, and show that whilst there were some nom-
inally signiﬁcant observations with copy number haplotypes, only
a total model of association with haemoglobin has a borderline
Table 1
Distribution of integer copy numbers.
Copy number Number
0 0
1 6
2 55
3 227
4 284
5 191
6 100
7 36
8 17
9 5
10 1
Total 922
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which haplotype data should be subsequently examined. More
speciﬁcally, a positive association with haemoglobin was observed
with the 2-copy haplotype (p = 0.021). There was also weak evi-
dence for a negative association with the 1-copy haplotype
(p = 0.045) but neither of these observations were supported when
including family structure and would not be signiﬁcant after multi-
ple testing.
4. Discussion
The PRT system for copy number measurement of CCL3L1 has
previously been shown to have a high degree of accuracy in integer
copy number prediction (Carpenter et al., 2011; Walker et al.,
2009). Here we adapted the PRT methodology for use with African
samples. African samples have previously been measured for
CCL3L1 copy number using another measurement system
(Gonzalez et al., 2005), and predicted to have a range of 2–14.Fig. 2. Distribution of total diploid copy numbers for subsets of samples for which haplot
The two distributions do not have signiﬁcantly different means.Our data suggests that the range in Tanzania is 1–10; however,
the integer copy numbers in this study were assigned from PRT
data which has sufﬁcient accuracy to identify discrete clusters con-
sistent with microsatellite data, whereas the previous data did not
fall into discrete clusters for integer determination (Gonzalez et al.,
2005) [their Supplementary Fig. S13], making it difﬁcult to com-
pare copy number ranges.
This study is the ﬁrst to examine association of susceptibility to
malaria phenotypes with CCL3L1 copy number. We used a well-
documented population from Tanzania and a family based study
to investigate the copy number association. A family-based ap-
proach overcomes problems of population admixture and stratiﬁ-
cation that can inﬂuence case-control studies. The malaria
phenotypes result from data collected over a number of years,
the use of multiple time-points should provide more information
than a single time point and thus a better portrayal of an individ-
ual’s susceptibility.
The heritability of haemoglobin level was 0.316, which is a good
value for genetic analysis. Whilst we have not been able to incor-
porate household effects into the heritability estimate due to the
SOLAR method, the value is generated from longitudinal data,
which generates a more robust measurement of heritability than
a single time-point. This value is similar to previous studies for
haemoglobin heritiabilities (Garner et al., 2000; Sala et al., 2008),
and suggests a high genetic contribution to haemoglobin levels.
The heritabilities of parasite load and mean number of clinical epi-
sodes of malaria data have been previously reported and are lower
than that for haemoglobin (Carpenter et al., 2009), suggesting that
the sample size required to detect genes that contribute to parasite
levels and clinical episodes will be higher than for haemoglobin
(Carpenter et al., 2009).
We found limited evidence for an inﬂuence of CCL3L1 copy
number on malaria phenotypes. The most interesting observationype composition could (black) or could not (white) be determined from segregation.
Fig. 3. Distribution of the haemoglobin data before and after correction for age, sex and parasite load. The residuals generated from the correction were normally distributed
and therefore no further transformation was made prior to genetic analysis.
Table 2
Distribution of copy number haplotypes.
Copy number haplotype Number
0 1
1 108
2 174
3 72
4 22
5 9
6 2
Total 388
Table 3
Number of individuals with recorded haemoglobin levels (g/l) in Nyamisati by year.
Year na Range (g/l) (all individuals) Geometric mean (95% CI)
1994 292 53–163 104.05 (98.49–109.6)
1995 652 16–171 107.69 (101.78–113.59)
1996 13b 43–126 88.53 (83.35–93.71)
1997 0
1998 152 48–153 112.09 (109.34–114.83)
1999 847 49–176 112.31 (107.08–117.53)
a n = number of individuals sampled.
b In 1996 only haemoglobin levels were tested only on clinical suspicion (preg-
nancy and/or clinical signs of anaemia).
Table 4
Variance components analysis using SOLAR. Values presented are p values for the
different components included. Bold ﬁgures correspond to p < 0.05.
Covariates Parasite load Clinical episodes Haemoglobin
Age n/sa 0.001 n/s
Sex n/s n/s n/s
Total copy number n/s 0.098 n/s
Ageb n/s-removedb 0.001 n/s-removed
Sexb n/s-removed n/s-removed n/s-removed
Total copy numberb n/s-removed 0.041 0.035
Age  sex n/s-removed 0.059 0.049
Sex  total copy number n/s-removed 0.034 n/s-removed
Sex  total copy numberb n/s-removed 0.063 n/s-removed
a Not signiﬁcant.
b Not signiﬁcant, and removed from the ﬁnal analysis.
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copy number was shown to have a weak, non-linear association,
and the allele speciﬁc analysis identiﬁed a positive association
with a two copy haplotype. Previous studies have found that high
levels of MIP-1a inhibit haematopoiesis, and therefore it is possible
that at lower copy numbers there is a correspondingly reduced le-
vel of MIP-1a, a signiﬁcantly reduced inhibition of haematopoiesis,
and ultimately less inﬂuence on malarial anaemia.
The evidence for the association between total copy number
and haemoglobin levels is weak, and is not signiﬁcant after correc-
tion for multiple testing. This may in part be due to lack of power,
especially with the QTDT analysis where the sample size was sig-
niﬁcantly reduced. However, the evidence for a polygenic compo-
nent to haemoglobin levels is strong, and it is likely therefore
that some of the genetic factors inﬂuencing this quantitative phe-
notype will have small, but signiﬁcant, biological effects, as has
been observed previously for malarial anaemia (Anyona et al.,
2011; Awandare et al., 2009; Ong’echa et al., 2011 and reviewed
in Perkins et al. (2011)) and observed in other complex traits (Alt-
müller et al., 2001; Maher, 2008). The evidence for association is
similar for the haemoglobin data both with and without the cor-
rection for parasite load, as is described in Section 2. This correc-
tion applies to relatively few individuals in our data-set, and to
ascertain the role of malaria on the haemoglobin phenotype would
require more detailed investigation. This population has not been
screened for other genetic determinants that may inﬂuence hae-
moglobin status. Furthermore, there are a number of causes of
anaemia in malaria endemic areas, and whilst persistent malaria
infection is a major factor there are other important contributory
causes including co-infections with HIV-1 (Davenport et al.,
2010), and malnutrition.
Cerebral malaria results from the sequestration of parasitised
red blood cells and leucocytes in the brain. CCR5, the receptor for
MIP-1a is required for trafﬁcking of leucocytes and CD8+ cells to
the brain and thus for cerebral malaria to develop in infected mice,
and it has been observed that CCR5 deﬁcient mice are resistant to
cerebral malaria (Belnoue et al., 2003). An upregulation of CCR5
expression and also an upregulation of MIP-1a in the brains and
lungs of malaria infected mice has been observed (Belnoue et al.,
2008). This study population does not have any cases of cerebral
Table 5
Tests of association between copy number haplotypes and the quantitative malaria phenotypes. Values presented are p values for total and within-family tests of association
using QTDT. Signiﬁcant p values are in bold.
Parasite load Clinical episodes Haemoglobin
Total association Within-family association Total association Within-family association Total association Within-family association
Global score n/s n/s n/s n/s 0.063 n/s
Copy number haplotype
0 0.0237 n/s n/s n/s n/s n/s
1 n/s n/s 0.026 n/s 0.045 n/s
2 n/s n/s n/s n/s 0.021 n/s
3 n/s n/s n/s n/s n/s n/s
4 n/s n/s n/s 0.028 n/s n/s
5 n/s n/s 0.029 n/s n/s n/s
6 n/s n/s n/s n/s n/s n/s
7 n/s n/s n/s n/s n/s n/s
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copy number in a study population that presented with cerebral
malaria as a phenotype.
Furthermore malaria infection during pregnancy is associated
with poor birth outcomes, due, in part, to sequestered parasites
in the placenta and results in monocyte penetration into the pla-
cental intervillous space (Ordi et al., 1998) and a localised immune
response (Moormann et al., 1999). Malaria infected mothers have
been shown to have a 3-fold increased expression of CCR5
(Tkachuk et al., 2001), and MIP-1a has been shown to be associated
with placental malaria and with monocyte density (Abrams et al.,
2003). Therefore further investigations of CCL3L1 copy number
with placental malaria may also be of interest.
The range of CCL3L1 copy numbers observed in this African pop-
ulation is greater than that observed with European populations,
though it is not fully understood how this divergence has evolved
or been maintained. It is probable that the observed diversity of
copy number haplotypes has been generated both by the expan-
sion and/or reduction of copy variable repeats units combined with
the mutation of microsatellites within each repeat unit. Mice do
not have an orthologue of CCL3L1 and have only a CCL3 orthologue.
Chimpanzees have been shown not to be copy variable for CCL3L1
(Perry et al., 2008) (and our unpublished data). It is thus possible
that this locus was at high copy number in the human ancestral
population and has reduced to low average copy number after a
bottleneck associated with European divergence, or there is selec-
tion acting, either upon African populations to maintain higher
copy numbers or in Europeans for a lower copy number. Our data
shows that the African population sampled here does show a large
range of total CCL3L1 copy numbers and that the constituent alleles
are variable and diverse. This is the ﬁrst time that African CCL3L1
copy number haplotypes have been described, and are in contrast
to our observation of European CCL3L1 copy number haplotypes
described previously (Walker et al., 2009), and also for the 30
HapMap CEPH trios which show signiﬁcantly less variability of
microsatellite alleles in phased haplotypes (see Supplementary
Table 3). This is not unexpected, as African populations have
greater diversity than European populations at a number of loci
(The 1000 Genomes Project Consortium, 2010). However, whether
the contrast of population speciﬁc CCL3L1 haplotype diversity is a
consequence of a founder effect or selection cannot be simply
inferred from our data.
To conclude, we have found weak evidence for an associa-
tion with lower CCL3L1 copy numbers and protection from
anaemia. The data also demonstrate that African populations
maintain a wide copy number distribution of CCL3L1 on diverse
haplotype backgrounds. It is still unclear whether this observed
difference in CCL3L1 copy number diversity is generated by
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